The advent of digital health technologies offers promising tools for monitoring hydroxychloroquine's effects and managing its side effects more efficiently. Wearable devices and mobile health apps could enable patients on
hydroxychlor 200 mg to track their symptoms, medication adherence, and even detect early signs of adverse reactions, facilitating timely interventions and personalized care approaches.